1 曲红,金琳羚,何梦钰,等.149例经手术病理确诊中青年非小细胞肺癌患者临床分析[J].徐州医科大学学报,2020,40(1):55-59. 2 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:a cancer journal for clinicians,2024,74(3):229-263. 3 张可可,卢宁.中青年与老年人肺癌术后患者的临床病理特点和预后因素[J].吉林医学,2023,44(12):3443-3447. 4 苏鑫,范雯怡,徐昕晔,等.中国居民癌症等四大慢病危险因素及归因疾病负担分析[J].中国癌症防治杂志,2024,16(4):442-447. 5 徐灵燕,李倩妮,李健,等.非小细胞肺癌患者首次住院天数对治疗质量的影响分析[J].实用肿瘤学杂志,2024,38(04):221-226. 6 Lohr KN.Medicare:a strategy for quality assurance[J].J Qual Assur,1991,13(1):10-13. 7 Chen Y,Gong X,Zhong W,et al.Evaluation of a multilevel program to improve clinician adherence to management guidelines for acute ischemic stroke[J].JAMA network open,2022,5(5):e2210596. 8 王潇,陈高瑛,尚艳.安罗替尼治疗晚期非小细胞肺癌患者的疗效及对患者生活质量的影响[J].医学临床研究,2025,42(06):920-922+926. 9 刘颖颖.晚期非小细胞肺癌患者采用培美曲塞联合顺铂化疗的临床效果分析[J].中国实用医药,2025,20(14):68-71. 10 栗景坤,李习,刘美娜.基于评价指标的非小细胞肺癌治疗质量影响因素分析[J].中国医院统计,2018,25(6):405-409. 11 田园,侯爽,刘梦洋,等.基于Beta回归的非小细胞肺癌治疗质量影响因素研究[J].实用预防医学,2022,29(4):406-410. 12 Hin LY,Wang YG.Working-correlation-structure identification in generalized estimating equations[J].Statistics in Medicine,2009,28(4):642-658. 13 Lipsitz SR,Kim K,Zhao L.Analysis of repeated categorical data using generalized estimating equations[J].Statistics in Medicine,1994,13(11):1149-1163. 14 韩琳艾.基于广义估计方程探讨患者报告结局在慢性心力衰竭患者预后中的作用[D].山西医科大学,2023. 15 Bursac Z,Gauss CH,Williams DK,et al.Purposeful selection of variables in logistic regression[J].Source Code Biol Med,2008,16(3):17. 16 姚雪佩,白山奇,刘美娜.基于因果图模型的非小细胞肺癌治疗质量影响因素分析[J].实用肿瘤学杂志,2024,38(4):227-234. 17 Faghani A,Guo L,Wright ME,et al.Construction and case study of a novel lung cancer risk index[J].BMC Cancer,2022,22(1):1275. 18 王以平,都静,龚帅.立体定向放疗Ⅰ期非小细胞肺癌患者的生存质量及预后相关影响因素分析[J].实用癌症杂志,2023,38(7):1145-1147+1151. 19 杨维维,漆静.非小细胞肺癌患者年龄与临床病理特征、预后的关系研究[J].实用心脑肺血管病杂志,2021,29(6):63-67. 20 曹运新.老中青年肺癌437例临床对比分析[J].现代医药卫生,2011,27(7):1003-1004. 21 唐善卫.年轻非小细胞肺癌患者(<50岁)的临床病理特征及预后分析[D].扬州大学,2019. 22 Wagenschieber E,Blunck D.Impact of reimbursement systems on patient care-a systematic review of systematic reviews.Health Econ Rev,2024,14(1):22. 23 Kenessey I,Parrag P,Dobozi M,et al.The epidemiology of lung cancer in Hungary based on the characteristics of patients diagnosed in 2018[J].Scientific Reports,2024,14(1):20064. 24 Mithoowani H,Febbraro M.Non-small-cell lung cancer in 2022:A review for general practitioners in oncology[J].Curr Oncol,2022,29(3):1828-1839. 25 徐瑜,李梦侠.《CSCO非小细胞肺癌诊疗指南2024》更新解读[J].现代医药卫生,2024,40(11):1801-1808. |